X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1949) 1949
Publication (95) 95
Book Review (20) 20
Book Chapter (15) 15
Conference Proceeding (2) 2
Dissertation (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1376) 1376
female (843) 843
male (822) 822
soluble interleukin-2 receptor (740) 740
adult (675) 675
middle aged (635) 635
immunology (464) 464
aged (404) 404
index medicus (357) 357
receptors, interleukin-2 - blood (308) 308
cytokines (295) 295
expression (252) 252
animals (238) 238
soluble interleukin-2 receptors (238) 238
oncology (231) 231
adolescent (227) 227
tumor-necrosis-factor (197) 197
interleukin-2 (191) 191
solubility (191) 191
receptors, interleukin-2 - analysis (177) 177
hematology (163) 163
enzyme-linked immunosorbent assay (161) 161
prognosis (160) 160
t-lymphocytes - immunology (157) 157
mice (143) 143
lymphocytes (142) 142
cells (141) 141
biomarkers - blood (137) 137
receptors, interleukin-2 - metabolism (137) 137
serum (135) 135
child (134) 134
psychiatry (134) 134
interferon-gamma (133) 133
activation (132) 132
disease (132) 132
t-cells (132) 132
aged, 80 and over (127) 127
lymphocyte activation (126) 126
neurosciences (121) 121
rheumatology (118) 118
cytokines - blood (115) 115
inflammation (105) 105
case-control studies (104) 104
receptor (102) 102
interleukin-2 receptor (101) 101
soluble interleukin-2 (99) 99
biochemistry & molecular biology (96) 96
medicine, research & experimental (96) 96
necrosis-factor-alpha (96) 96
interleukins (92) 92
invitro (92) 92
rheumatoid-arthritis (92) 92
child, preschool (89) 89
cell biology (88) 88
soluble il-2 receptor (88) 88
pharmacology & pharmacy (87) 87
cancer (86) 86
t cells (85) 85
interleukin-6 - blood (84) 84
biomarkers (83) 83
serum levels (82) 82
cytokine (81) 81
flow cytometry (80) 80
peripheral-blood (79) 79
disease-activity (78) 78
major depression (78) 78
analysis (76) 76
il-2 receptor (76) 76
medicine, general & internal (76) 76
factor-alpha (75) 75
cells, cultured (74) 74
therapy (74) 74
treatment outcome (74) 74
clinical neurology (73) 73
il-2 (73) 73
immunotherapy (73) 73
interleukin-6 (73) 73
severity of illness index (71) 71
gastroenterology & hepatology (70) 70
neopterin (70) 70
prospective studies (69) 69
c-reactive protein (68) 68
interleukin-2 - blood (68) 68
soluble interleukin-2-receptor (68) 68
schizophrenia (67) 67
reference values (66) 66
diagnosis (65) 65
infection (65) 65
leukemia (65) 65
medicine & public health (65) 65
biomarkers, tumor - blood (64) 64
research (64) 64
transplantation (64) 64
respiratory system (61) 61
infant (59) 59
pathology (59) 59
time factors (59) 59
research article (58) 58
systemic lupus-erythematosus (58) 58
children (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1893) 1893
Japanese (20) 20
German (15) 15
French (10) 10
Spanish (10) 10
Korean (6) 6
Polish (6) 6
Czech (4) 4
Russian (4) 4
Chinese (1) 1
Italian (1) 1
Lithuanian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Postepy Dermatologii i Alergologii, ISSN 1642-395X, 08/2016, Volume 33, Issue 4, pp. 263 - 268
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0128998
A variety of cytokine/cytokine receptor systems affect the biological behavior of acute leukemia cells. However, little is known about the clinical relevance... 
MAINTENANCE INTENSIFICATION THERAPY | SOLUBLE INTERLEUKIN-2-RECEPTOR | CELLS | INDIVIDUALIZED INDUCTION THERAPY | GM-CSF | MULTIDISCIPLINARY SCIENCES | ACUTE MYELOGENOUS LEUKEMIA | CONSOLIDATION THERAPY | PROLIFERATION | CLINICAL IMPORTANCE | HEMATOPOIETIC GROWTH-FACTORS | Prognosis | Leukemia, Myeloid, Acute - pathology | Humans | Leukemia, Myeloid, Acute - metabolism | Middle Aged | Male | Risk | Phenotype | Leukemia, Myeloid, Acute - diagnosis | Interleukin-2 Receptor alpha Subunit - metabolism | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Cytokines - pharmacology | Karyotype | Leukemia, Myeloid, Acute - genetics | Flow cytometry | Leukemia | Interleukin | Cytokine receptors | Chains | Oncology | Kinases | Macrophages | Interleukin 6 | Receptors | Interleukin 2 | Granulocyte colony-stimulating factor | Risk assessment | Cell cycle | Bone marrow | CD25 antigen | Colony-stimulating factor | Granulocyte colony-stimulating factor receptors | University graduates | Glycoprotein gp130 | Interleukin 2 receptors | Cytokines | Internal medicine | Hematology | Granulocyte-macrophage colony-stimulating factor | Myeloid leukemia | Patients | c-Kit protein | Medicine | Cytometry | Chemotherapy | Leukocytosis | Medical prognosis | Stem cells | Cytogenetics | Lymphomas | Mutation | Acute myeloid leukemia | Cancer
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2017, Volume 179, Issue 1, pp. 20 - 35
CD 25 (also termed IL 2 RA ) forms one component of the high‐affinity heterotrimeric interleukin 2 ( IL 2) receptor on activated T cells. Its affinity for IL 2... 
regulatory T cells | interleukin‐2 receptor | 25 targeted therapy | 25‐expressing malignancies | anti | CD25-expressing malignancies | CD25 | interleukin-2 receptor | anti-CD25 targeted therapy | MONOCLONAL-ANTIBODY TREATMENT | SERUM-SOLUBLE INTERLEUKIN-2-RECEPTOR | FOLLICULAR LYMPHOMA | REGULATORY T-CELLS | IMMUNOTOXIN RFT5-SMPT-DGA | INTERLEUKIN-2-RECEPTOR ALPHA-CHAIN | RETROSPECTIVE ANALYSIS | HEMATOLOGY | C-RECEPTOR POLYMORPHISMS | PHASE-I | HEMATOLOGIC MALIGNANCIES | Interleukin-2 - metabolism | Neoplasms - metabolism | Immunomodulation - drug effects | T-Lymphocytes, Regulatory - metabolism | Interleukin-2 Receptor alpha Subunit - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Humans | Receptors, Interleukin-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Molecular Targeted Therapy | Neoplasms - drug therapy | T-Lymphocytes, Regulatory - immunology | Gene Expression Regulation - drug effects | T-Lymphocytes, Regulatory - drug effects | Interleukin-2 Receptor alpha Subunit - genetics | Interleukin-2 Receptor alpha Subunit - metabolism | Neoplasms - genetics | Signal Transduction - drug effects | Neoplasms - immunology | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Interleukin-2 Receptor alpha Subunit - immunology | Biological products | T cells | Stem cells | Cancer | Medical research | Interleukin 2 receptors | Hematology | Immunomodulation | Interleukin | Clinical trials | Lymphocytes T | Modulators | Immunotoxins | Signal transduction | Signaling | Interleukin 2 | Lymphocytes | CD25 antigen | Affinity | Tumors | Immune system | Index Medicus
Journal Article
Journal Article
Journal Article
ANTICANCER RESEARCH, ISSN 0250-7005, 09/2019, Volume 39, Issue 9, pp. 5115 - 5122
Background/Aim: Although various prognostic indices for follicular lymphoma (FL) have been proposed, they are designed specifically for patients requiring... 
Soluble interleukin-2 receptor | TRIAL | follicular lymphoma | prognostic factor | MODELS | ONCOLOGY | RITUXIMAB | RISK | Prognosis | Cytokines | Interleukin | Management | Lymphoma | Survival | Patients | Impact analysis | Interleukin 2 | Medical prognosis | Biomarkers | Bioindicators | Lymphomas | Diagnosis
Journal Article
Sarcoidosis Vasculitis and Diffuse Lung Diseases, ISSN 1124-0490, 2017, Volume 34, Issue 2, pp. 122 - 129
Sarcoidosis is a systemic inflammatory disease characterized by granulomatous inflammation. The soluble interleukin-2 receptor (sIL-2R) is used as a biomarker... 
Soluble interleukin-2 receptor | Immunopathology | Biomarker | Sarcoidosis | PROTEOLYTIC CLEAVAGE | ALPHA-SUBUNIT | soluble interleukin-2 receptor | sarcoidosis | SERUM | RELEASE | biomarker | DISEASE-ACTIVITY | BINDS INTERLEUKIN-2 | immunopathology | RESPIRATORY SYSTEM | ALVEOLAR MACROPHAGES | IL-2 RECEPTOR | INFLAMMATORY ACTIVITY | T-CELLS
Journal Article
by Chen, XH and Shen, B and Xiang, FF and Guo, M and Zou, JZ and Liu, ZH and Lv, W and Cao, XS and Ding, XQ and Zhang, BH
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, ISSN 1341-9625, 09/2019, Volume 24, Issue 9, pp. 1151 - 1160
Background Patients on chronic hemodialysis (HD) have an increased incidence of malignancy due to decreased immunity. Soluble interleukin-2 receptor (sIL-2R),... 
Malignancy-related mortality | Hemodialysis | Malignancy event | MECHANISMS | CANCER | RECEPTOR-ALPHA | Soluble interleukin-2 receptor | DIALYSIS PATIENTS | TUMOR ESCAPE | ONCOLOGY | RESISTANCE | IL-2 RECEPTOR | EXPRESSION | STAGE RENAL-DISEASE | T-CELLS | Medicine, Experimental | Medical research | Rankings | Interleukins | Mortality
Journal Article